First MS clinical trial with focus on people who cannot walk to start recruiting participants
The first multiple sclerosis (MS) clinical trial focusing only on people who cannot walk will start recruiting participants next year. The ChariotMS study will test whether cladribine tablets (Mavenclad), which
Read More